In most cases, PP2A inactivation in cancer is achieved by non-genomic mechanisms involving overexpression of endogenous PP2A inhibitory proteins, such as cancerous inhibitor of PP2A (CIP2A) and PP2A methylesterase-1 (PME-1) [9–12]. This evidence concerns the gene PTPA and cancer.